The first biotech drug, human insulin produced in genetically modified bacteria, was approved by FDA
On Oct. 28, 1982, the U.S. Food and Drug Administration (FDA) approved Humulin, Eli Lily’s recombinant insulin made from Genentech’s specially modified bacteria.
It was the first drug produced through recombinant DNA technology and among the first genetically engineered products to be available to consumers.
Tags:
Source: U.S. Food and Drug Administration
Credit:
